SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-005883
Filing Date
2020-05-08
Accepted
2020-05-08 08:32:05
Documents
53
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q edit-20200508x10q.htm   iXBRL 10-Q 1571464
2 EX-31.1 edit-20200331xex31d1.htm EX-31.1 20634
3 EX-31.2 edit-20200331xex31d2.htm EX-31.2 20192
4 EX-32.1 edit-20200331xex32d1.htm EX-32.1 13510
  Complete submission text file 0001558370-20-005883.txt   5209535

Data Files

Seq Description Document Type Size
5 EX-101.SCH edit-20200508.xsd EX-101.SCH 24922
6 EX-101.CAL edit-20200508_cal.xml EX-101.CAL 40657
7 EX-101.DEF edit-20200508_def.xml EX-101.DEF 87629
8 EX-101.LAB edit-20200508_lab.xml EX-101.LAB 306839
9 EX-101.PRE edit-20200508_pre.xml EX-101.PRE 212639
32 EXTRACTED XBRL INSTANCE DOCUMENT edit-20200508x10q_htm.xml XML 906393
Mailing Address 11 HURLEY ST. CAMBRIDGE MA 02141
Business Address 11 HURLEY ST. CAMBRIDGE MA 02141 617-401-9000
Editas Medicine, Inc. (Filer) CIK: 0001650664 (see all company filings)

IRS No.: 464097528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37687 | Film No.: 20858820
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences